Hematologic Oncology

The European Commission has approved the antibody-drug conjugate gemtuzumab ozogamicin (Mylotarg) for use in combination with daunorubicin and cytarabine for the treatment of patients aged 15 years and older with newly diagnosed, CD33-positive acute myeloid... 
Read More >>
top border
top border
Featured Programs
2015 ASH Annual Meeting Highlights
Gina Columbus highlights findings from the 2015 American Society of Hematology Annual Meeting and Exposition, including advances in multiple myeloma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia.View Now
Multiple Myeloma: Emerging Concepts in Management
This Peer Exchange discussion, moderated by A. Keith Stuart, MB, ChB, highlights the most up-to-date information available on the emerging concepts in the management of multiple myeloma. View Now

 

Featured Video
Immunotherapy in the Treatment of Follicular Lymphoma
Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

Gina Columbus

Gina Columbus highlights the latest news in oncology in this week's OncLive News Network.

Publication Bottom Border
Border Publication
x